115 related articles for article (PubMed ID: 8672478)
1. Identification of S-(2,3-dihydroxypropyl)cystein in a macrophage-activating lipopeptide from Mycoplasma fermentans.
Mühlradt PF; Meyer H; Jansen R
Biochemistry; 1996 Jun; 35(24):7781-6. PubMed ID: 8672478
[TBL] [Abstract][Full Text] [Related]
2. Purification and partial biochemical characterization of a Mycoplasma fermentans-derived substance that activates macrophages to release nitric oxide, tumor necrosis factor, and interleukin-6.
Mühlradt PF; Frisch M
Infect Immun; 1994 Sep; 62(9):3801-7. PubMed ID: 8063396
[TBL] [Abstract][Full Text] [Related]
3. Mycoplasma fermentans-derived lipid inhibits class II major histocompatibility complex expression without mediation by interleukin-6, interleukin-10, tumor necrosis factor, transforming growth factor-beta, type I interferon, prostaglandins or nitric oxide.
Frisch M; Gradehandt G; Mühlradt PF
Eur J Immunol; 1996 May; 26(5):1050-7. PubMed ID: 8647166
[TBL] [Abstract][Full Text] [Related]
4. MDHM, a macrophage-activating product of Mycoplasma fermentans, stimulates murine macrophages to synthesize nitric oxide and become tumoricidal.
Ruschmeyer D; Thude H; Mühlradt PF
FEMS Immunol Med Microbiol; 1993 Oct; 7(3):223-9. PubMed ID: 8275053
[TBL] [Abstract][Full Text] [Related]
5. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
J Exp Med; 1997 Jun; 185(11):1951-8. PubMed ID: 9166424
[TBL] [Abstract][Full Text] [Related]
6. Structure and specific activity of macrophage-stimulating lipopeptides from Mycoplasma hyorhinis.
Mühlradt PF; Kiess M; Meyer H; Süssmuth R; Jung G
Infect Immun; 1998 Oct; 66(10):4804-10. PubMed ID: 9746582
[TBL] [Abstract][Full Text] [Related]
7. Mycoplasma fermentans-derived high-molecular-weight material induces interleukin-6 release in cultures of murine macrophages and human monocytes.
Quentmeier H; Schmitt E; Kirchhoff H; Grote W; Mühlradt PF
Infect Immun; 1990 May; 58(5):1273-80. PubMed ID: 2323816
[TBL] [Abstract][Full Text] [Related]
8. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
[TBL] [Abstract][Full Text] [Related]
9. Activation of mitogen-activated protein kinase pathways by Mycoplasma fermentans membrane lipoproteins in murine macrophages: involvement in cytokine synthesis.
Rawadi G; Ramez V; Lemercier B; Roman-Roman S
J Immunol; 1998 Feb; 160(3):1330-9. PubMed ID: 9570551
[TBL] [Abstract][Full Text] [Related]
10. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G
J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908
[TBL] [Abstract][Full Text] [Related]
11. MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits.
Mühlradt PF; Schade U
Infect Immun; 1991 Nov; 59(11):3969-74. PubMed ID: 1937755
[TBL] [Abstract][Full Text] [Related]
12. Induction of macrophage growth by lipoprotein.
Yui S; Mizuno D; Yamazaki M
Jpn J Exp Med; 1985 Feb; 55(1):29-35. PubMed ID: 4032828
[TBL] [Abstract][Full Text] [Related]
13. Lipid-associated membrane proteins of Mycoplasma fermentans and M. penetrans activate human immunodeficiency virus long-terminal repeats through Toll-like receptors.
Shimizu T; Kida Y; Kuwano K
Immunology; 2004 Sep; 113(1):121-9. PubMed ID: 15312143
[TBL] [Abstract][Full Text] [Related]
14. Immunostimulants and Toll-like receptor ligands obtained by screening combinatorial lipopeptide collections.
Reutter F; Jung G; Baier W; Treyer B; Bessler WG; Wiesmüller KH
J Pept Res; 2005 Mar; 65(3):375-83. PubMed ID: 15787968
[TBL] [Abstract][Full Text] [Related]
15. Solid-phase synthesis of biologically active lipopeptides as analogs for spirochetal lipoproteins.
DeOgny L; Pramanik BC; Arndt LL; Jones JD; Rush J; Slaughter CA; Radolf JD; Norgard MV
Pept Res; 1994; 7(2):91-7. PubMed ID: 8012126
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 6-independent signaling by diacylated lipopeptides.
Buwitt-Beckmann U; Heine H; Wiesmüller KH; Jung G; Brock R; Akira S; Ulmer AJ
Eur J Immunol; 2005 Jan; 35(1):282-9. PubMed ID: 15580661
[TBL] [Abstract][Full Text] [Related]
17. Differential posttranslational processing confers intraspecies variation of a major surface lipoprotein and a macrophage-activating lipopeptide of Mycoplasma fermentans.
Calcutt MJ; Kim MF; Karpas AB; Mühlradt PF; Wise KS
Infect Immun; 1999 Feb; 67(2):760-71. PubMed ID: 9916088
[TBL] [Abstract][Full Text] [Related]
18. Structural significance of the benzoyl group at the C-3'-N position of paclitaxel for nitric oxide and tumor necrosis factor production by murine macrophages.
Kirikae T; Ojima I; Ma Z; Kirikae F; Hirai Y; Nakano M
Biochem Biophys Res Commun; 1998 Apr; 245(3):698-704. PubMed ID: 9588177
[TBL] [Abstract][Full Text] [Related]
19. Relation between the biologic activities and chemical structures of synthetic microbial lipopeptide analogs in mice.
Shimizu T; Haketa Y; Iwamoto Y; Yanagihara Y; Kurimura M; Ochiai A; Achiwa K
Mol Biother; 1992 Dec; 4(4):184-7. PubMed ID: 1476672
[TBL] [Abstract][Full Text] [Related]
20. Inducible macrophage apoptosis following sepsis is mediated by cysteine protease activation and nitric oxide release.
Williams TE; Ayala A; Chaudry IH
J Surg Res; 1997 Jul; 70(2):113-8. PubMed ID: 9245558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
